Health Care • Medical/Nursing Services
$124.34 ▲ +2.16
(+1.77%)
MKT CAP: $2.32B • VOL: 331.6K
52W L $88 52W H $127
ADUS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.42B | $1.15B | $1.06B |
| YoY Revenue Growth % | +23.2% | +9.1% | — |
| Gross Profit | $461.9M | $375.0M | — |
| Gross Margin % | 32.5% | 32.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $138.6M | $102.7M | $91.0M |
| Operating Margin % | 9.7% | 8.9% | 8.6% |
| Net Income (GAAP) | $95.9M | $73.6M | $62.5M |
| EBITDA (Normalized) | $144.8M | $107.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $111.5M | $116.4M | $112.2M |
| Capital Expenditures (CapEx) | $7.7M | $6.0M | — |
| Free Cash Flow (FCF) | $103.8M | $110.4M | $112.2M |
| FCF Margin % | 7.3% | 9.6% | 10.6% |
| Return on Invested Capital (ROIC %) | 9.1% | 7.4% | — |
| Cash & Short-Term Equivalents | — | $98.9M | — |
| Total Debt (Short + Long Term) | $121.0M | $218.4M | — |
| Total Stockholders' Equity | $1.09B | $970.5M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ADUS.